BioCryst Pharmaceuticals, Inc. (BCRX)

8.59 -0.10 (-1.15%) USD  |  NASDAQ  |  Mar 04, 13:31
More

BioCryst Pharmaceuticals Price to CFO Per Share (TTM)

Price to CFO Per Share (TTM) Chart

View Price to CFO Per Share (TTM) for BCRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to CFO Per Share (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price to CFO Per Share (TTM) Range, Past 5 Years

View Price to CFO Per Share (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to CFO Per Share (TTM) Benchmarks

View Price to CFO Per Share (TTM) Benchmarks
Start Trial
Anika Therapeutics, Inc. Upgrade
KalVista Pharmaceuticals, Inc. --
Lantheus Holdings, Inc. Upgrade
Plus Therapeutics, Inc. --
BioStem Technologies, Inc. Upgrade